Permira
http://www.permira.comPermira is an international private equity firm headquartered in London, England. The firm acts as an advisor to the nineteen Permira Funds, worth approximately 22 billion euros. Since 1985, the Permira funds have invested in over 180 transactions in over fifteen different countries.
View Older Stories View More Recent Stories
-
Net revenues at sneaker maker Golden Goose rose 13% last year
-
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry
-
Motus Extends Reach with Strategic Acquisition of Everlance
-
Form 13F-NT Permira Growth Opportuni For: Dec 31
-
Form 13F-NT Permira V G.P. Ltd For: Dec 31
-
Form 13F-NT Permira VII GP S.a r.l. For: Dec 31
-
Form 13F-HR Permira Holdings LTD For: Dec 31
-
Informatica Reports Fourth Quarter and Full-Year 2024 Financial Results
-
US-Based Private Equity Firms Dominate Top 10 Spots in Latest Large Buyout Performance Ranking
-
Accelerating Into 2025, Engine Names SaaS Veteran Jenny Decker as CFO
-
Ares Management Announces Fourth Quarter and Full Year 2024 U.S. Direct Lending Origination Activity
-
INAUGURAL LEVERAGED FINANCE FIGHTS MELANOMA LONDON RAISES £1.4 MILLION BENEFITING THE MELANOMA RESEARCH ALLIANCE
-
Alibaba's Tsai-backed firm buys 12% of Italian luxury sneaker maker Golden Goose
-
Permira, Blackstone weigh multi-billion-euro Mobile.de IPO, sources say
-
PharmaCord Announces Appointment of Robert Truckenmiller as CEO
-
Exclusive Networks: Press Release Dated 16 January 2025
-
Engine Named Best Midsize Colorado Company to Work For by Built In For the Sixth Consecutive Year
-
Neuraxpharm to further grow branded business with the acquisition of two leading narcolepsy treatments, Provigil® and Nuvigil®
-
Engine’s Elia Wallen Named CEO of the Year by ColoradoBiz Magazine
-
Press Release on the Filing of a Draft Offer Document Relating to the Simplified Tender Offer for the Shares of Exclusive Networks
-
Engine Launches New Features to Boost Hotel Occupancy Year-Round and Help Hotels Win More Group Bookings
-
Change in the Composition of the Exclusive Networks SA Board of Directors
-
Cannae Holdings eyes participating in deal for Rapid7, quits group with activist
-
Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies
-
Exabeam Appoints Mike Byron as Chief Financial Officer
-
Exclusive Networks: Date of Payment of the Exceptional Distribution Approved by Shareholders on October 31, 2024
-
Exclusive Networks: Successful Syndication and Finalisation of the Group's Refinancing
-
CommentSold Launches ModelMe: The First Practical AI Tool To Model Real Clothes on Real People
-
IHG Hotels & Resorts Luxury & Lifestyle Collection Celebrates Cozy Season with Exclusive Minted Holiday Partnership
-
Welsh, Carson, Anderson & Stowe Appoints Four New General Partners
-
Form 13F-NT Permira Growth Opportuni For: Sep 30
-
Form 13F-NT Permira V G.P. Ltd For: Sep 30
-
Form 13F-HR Permira Holdings LTD For: Sep 30
-
Form 13F-NT Permira VII GP S.a r.l. For: Sep 30
-
Neuraxpharm reports another year of sustained growth and international expansion
-
Clearwater Analytics Holdings, Inc. (CWAN) Launches 25M Share Secondary Offering
-
Clearwater Analytics Announces Launch of Secondary Offering of Class A Common Stock
-
Informatica (INFA) Prices 16M Share Secondary Offering at $25.50/sh
-
Informatica Announces Pricing of Secondary Public Offering of Common Stock
-
Informatica (INFA) Launches 16M Share Secondary Offering
-
Informatica Announces Launch of Secondary Public Offering of Common Stock
-
BioCatch continues rapid expansion through Q3, grows ARR by 40% year-over-year
-
Exclusive Networks – Third Quarter 2024 Financial Update
-
Informatica Reports Third Quarter 2024 Financial Results
-
Blackstone Closes First Series of Evergreen Institutional U.S. Direct Lending Fund with $22 Billion of Investable Capital; Brings Global Direct Lending Platform to over $123 Billion in AUM
-
Minted Partners With Petite Plume on Holiday Card Collection
-
Spanish drugmaker Rovi to keep third-party manufacturing business
-
Genesys confidentially files for US IPO as AI boom drives demand
-
Activist Jana builds Lamb Weston stake, pushes for possible sale
-
Road Warriors Are Spending More Time Traveling for Work; Engine’s Powering Travel Trends Report Reveals How They’re Faring on the Road

